Impact of Immunomodulatory Treatment on Leukocyte Cytokine Production in Multiple Sclerosis Patients and Healthy Donors

Publisher： Karger

E-ISSN： 1423-0216|16|6|385-391

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.16, Iss.6, 2009-07, pp. : 385-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

By  

Neuroimmunomodulation, Vol. 21, Iss. 6, 2014-05 ,pp. : 291-296

Karger

Access to resources Recommend Favorite

Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease

By  

Neuroimmunomodulation, Vol. 23, Iss. 1, 2015-11 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

The Immunomodulatory Effect of the Antidepressant Sertraline in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 18, Iss. 2, 2010-11 ,pp. : 117-122

Karger

Access to resources Recommend Favorite

In vivo Effects of Mitoxantrone on the Production of Pro- and Anti-Inflammatory Cytokines by Peripheral Blood Mononuclear Cells of Secondary Progressive Multiple Sclerosis Patients

By  

Neuroimmunomodulation, Vol. 13, Iss. 2, 2006-11 ,pp. : 76-81

Karger

Access to resources Recommend Favorite

Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study

By  

Neuroimmunomodulation, Vol. 19, Iss. 5, 2012-03 ,pp. : 277-282

Karger

Access to resources Recommend Favorite